Higher doses of bisphosphonates further improve bone mass, architecture, and strength but not the tissue material properties in aged rats
about
Bisphosphonates and bone quality.Bisphosphonate-induced reductions in rat femoral bone energy absorption and toughness are testing rate-dependentEffect of sequential treatments with alendronate, parathyroid hormone (1-34) and raloxifene on cortical bone mass and strength in ovariectomized rats.Aging and estrogen status: a possible endothelium-dependent vascular coupling mechanism in bone remodeling.Prevention of glucocorticoid induced bone changes with beta-ecdysone.Differential maintenance of cortical and cancellous bone strength following discontinuation of bone-active agentsDeterminants of the mechanical behavior of human lumbar vertebrae after simulated mild fracture.Changing pattern of femoral fractures in osteogenesis imperfecta with prolonged use of bisphosphonatesAtypical femur fractures: a review of the evidence and its implication to clinical practiceProlonged alendronate treatment prevents the decline in serum TGF-β1 levels and reduces cortical bone strength in long-term estrogen deficiency rat modelShort-term effect of zoledronic acid upon fracture resistance of the mandibular condyle and femoral head in an animal model.Effects of combined treatment with ibandronate and pulsed electromagnetic field on ovariectomy-induced osteoporosis in rats.PTH(1-34) and zoledronic acid have differing longitudinal effects on juvenile mouse femur strength and morphology.Effect of osteoporosis treatment agents on the cortical bone osteocyte microenvironment in adult estrogen-deficient, osteopenic rats.
P2860
Q33683219-8693B7DB-4B54-4A6F-94CB-BE62597FD3BFQ33723995-A731390E-2884-43DD-9EED-C599793AB638Q34149279-B116FCFB-77C1-4493-87F3-5BB4C4078C06Q34489715-9A4AE147-34EA-461E-AC1E-1937D098EEC3Q35163490-FB2A69A7-B8BA-4022-9031-199299597064Q35229871-4CA8A873-BB19-42D5-B135-3072E82102D1Q35229984-A27DC020-883D-46E8-9CA8-9BE2E385A5C3Q35828143-0B580E00-EB21-43FC-BC26-5C8829CB4C9FQ36059445-86D28F79-B5EB-4058-8B58-51AD83E4D370Q37244297-6D2FB2AE-B1D1-4EDA-B297-68BF2ACAF406Q41289455-7A2754AA-FF2F-46D0-B28B-24E567697A1EQ51423055-317C592B-9AAD-423F-B7CB-A80FF09C17B0Q51800119-99AF02B2-5659-4924-BB8F-168C88A74678Q55384465-66905FF8-8838-4B34-AD12-618896C60434
P2860
Higher doses of bisphosphonates further improve bone mass, architecture, and strength but not the tissue material properties in aged rats
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Higher doses of bisphosphonate ...... terial properties in aged rats
@ast
Higher doses of bisphosphonate ...... terial properties in aged rats
@en
Higher doses of bisphosphonate ...... terial properties in aged rats
@nl
type
label
Higher doses of bisphosphonate ...... terial properties in aged rats
@ast
Higher doses of bisphosphonate ...... terial properties in aged rats
@en
Higher doses of bisphosphonate ...... terial properties in aged rats
@nl
prefLabel
Higher doses of bisphosphonate ...... terial properties in aged rats
@ast
Higher doses of bisphosphonate ...... terial properties in aged rats
@en
Higher doses of bisphosphonate ...... terial properties in aged rats
@nl
P2093
P2860
P1433
P1476
Higher doses of bisphosphonate ...... terial properties in aged rats
@en
P2093
Andrew J Burghardt
Daniel Heeren
Daniel P Nicolella
Michael G Kimiecik
Mohammad Shahnazari
Nancy E Lane
Robert O Ritchie
Sophi S Ionova-Martin
P2860
P304
P356
10.1016/J.BONE.2009.11.019
P577
2009-11-26T00:00:00Z